Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial - de Bono, JS; Oudard, S; Ozguroglu, M (Lancet Lond Engl, 2010)
et al.